In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UVA testing for sunscreens with avobenzone required -- FDA interim marketing notice.

This article was originally published in The Tan Sheet

Executive Summary

UVA TESTING OF SUNSCREENS WITH AVOBENZONE REQUIRED by FDA in an April 30 Federal Register notice allowing immediate use of the ingredient prior to publication of a final rule on sunscreens. The agency will allow the marketing of products containing the broad spectrum sunscreen ingredient avobenzone (Parsol 1789) in concentrations of up to 3% alone and in concentrations of 2%-3% in combination with specific Category I sunscreen ingredients.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts